Geode Capital Management
TELO icon

Geode Capital Management’s Telomir Pharmaceuticals TELO Stock Holding History

Geode Capital Management’s Portfolio TELO Stock Details TELO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$434K Buy
338,875
+89,789
+36% +$117K ﹤0.01% 3660
2026
Q1 		$324K Buy
249,086
+25,537
+11% +$32.6K ﹤0.01% 3746
2025
Q4 		$297K Buy
223,549
+27,519
+14% +$39.7K ﹤0.01% 3772
2025
Q3 		$273K Sell
196,030
-850
-0.4% -$1.28K ﹤0.01% 3832
2025
Q2 		$246K Sell
196,880
-232,372
-54% -$537K ﹤0.01% 3803
2025
Q1 		$1.39M Buy
429,252
+15,575
+4% +$68.1K ﹤0.01% 3187
2024
Q4 		$1.7M Buy
413,677
+174,940
+73% +$824K ﹤0.01% 3188
2024
Q3 		$1.53M Buy
238,737
+172,382
+260% +$840K ﹤0.01% 3207
2024
Q2 		$319K Buy
+66,355
New +$414K ﹤0.01% 3740

Other funds holding TELO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.04B AUM 22.7% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return

Geode Capital Management's TELO Position: Q2 2026 in Review

Geode Capital Management increased its Telomir Pharmaceuticals (TELO) stake by 36% in Q2 2026, buying an estimated $117K and bringing the position to 338,875 shares worth $434K. The position accounts for ﹤0.01% of the portfolio, ranked #3660.

Geode Capital Management first reported a position in TELO in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.7M in Q4 2024. 33 funds tracked by Wall St. Rank hold TELO as of Q2 2026.

  • Geode Capital Management held 338,875 shares of Telomir Pharmaceuticals worth $434K as of Q2 2026.
  • Geode Capital Management bought 89,789 Telomir Pharmaceuticals shares in Q2 2026, an estimated $117K.
  • Telomir Pharmaceuticals made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3660 holding.
  • Geode Capital Management first reported a position in Telomir Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Geode Capital Management's Telomir Pharmaceuticals position peaked at $1.7M in Q4 2024.
  • 33 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.